BRISDELLE (Sebela Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the BRISDELLE drug offered from Sebela Pharmaceuticals Inc.. This Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sebela Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | paroxetine |
SUBSTANCE NAME: | PAROXETINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-05-23 |
END MARKETING DATE: | 0000-00-00 |
BRISDELLE HUMAN PRESCRIPTION DRUG Details:
Item Description | BRISDELLE from Sebela Pharmaceuticals Inc. |
LABELER NAME: | Sebela Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.5(mg/1) |
START MARKETING DATE: | 2017-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54766-907_50361fc8-8fbb-1c45-e054-00144ff88e88 |
PRODUCT NDC: | 54766-907 |
APPLICATION NUMBER: | NDA204516 |
Other PAROXETINE MESYLATE Pharmaceutical Manufacturers / Labelers: